Abstract
This study aimed to quantify arterial volume distensibility in patients with branch retinal vein occlusion (BRVO) in comparison with normal subjects and to investigate factors associated with their differences. 40 normal subjects and 30 BRVO patients were studied. Brachial-ankle pulse wave velocity (baPWV) was measured to determine arterial volume distensibility. In comparison with the normal subjects, after adjusting for pulse pressure, baPWV in the BRVO patients was significantly higher by 2.3 m/s (P < 0.01) and arterial distensibility was significantly lower by 0.015% per mmHg (P < 0.01). No subject in the normal group had an arterial distensibility lower than 0.04% per mmHg, in comparison with 67% (20/30) in the BRVO group. Arterial distensibility was significantly related to systolic and diastolic blood pressures (SBP and DBP) and ageing for both groups (all P < 0.05), but in the BRVO group, blood pressures and ageing had more prominent effect on arterial volume distensibility. Peripheral arterial distensibility has been shown to be significantly lower in BRVO patients in comparison with normal subjects. The more prominent effect of SBP, DBP and ageing on arterial distensibility indicates the potential underlying mechanisms of the interaction between higher blood pressures, ageing and BRVO disease.
Introduction
Branch Retinal Vein Occlusion (BRVO) is a prevalent cause of vision loss, typically occurring at arteriovenous crossings where a thickened artery compresses a retinal vein. While the association between BRVO and systemic conditions like hypertension and diabetes is well-established, the specific elastic properties of peripheral arteries in these patients remain under-explored. This study investigates "arterial distensibility"—the ability of blood vessels to expand and contract—as a marker of systemic vascular health. By quantifying these properties, the research aims to determine if BRVO is a localized ocular event or a manifestation of broader systemic arterial stiffening.
Methods
The study compared 30 BRVO patients (diagnosed via fundoscopy and fluorescein angiography) with 40 age-matched healthy controls. Subjects were recruited from the Eye Center of the Second Affiliated Hospital, Zhejiang University.
To assess vascular health non-invasively, researchers utilized Brachial-Ankle Pulse Wave Velocity (baPWV). This metric measures the speed of pressure waves from the arm to the ankle; higher velocities indicate stiffer arteries. To provide a more direct measure of structural integrity, the authors applied the Zheng and Murray mathematical model to convert baPWV readings into arterial volume distensibility (% volume change per mmHg). Results were adjusted for pulse pressure to isolate intrinsic vessel wall changes from transient blood pressure fluctuations. Additionally, biochemical markers, including blood glucose and lipid profiles, were recorded.
Results
The analysis revealed significant differences in vascular stiffness between the two groups. After adjusting for pulse pressure, the BRVO group exhibited a baPWV that was 2.3 m/s higher than the control group ($P < 0.01$). Correspondingly, arterial distensibility was significantly lower in BRVO patients by 0.015% per mmHg ($P < 0.01$).
A critical clinical threshold was observed: while no healthy subjects had a distensibility below 0.04% per mmHg, 67% (20/30) of BRVO patients fell below this value. Furthermore, BRVO patients showed a heightened sensitivity to aging and hypertension. For instance, an age increase from 45 to 65 years was associated with a 35% decrease in distensibility in the BRVO group, nearly double the 18% decrease seen in healthy controls. Similarly, a rise in systolic blood pressure from 90 to 150 mmHg resulted in a 38% drop in distensibility for BRVO patients versus 30% for controls. Interestingly, biochemical markers like cholesterol and glucose did not significantly correlate with distensibility in this cohort.
Discussion
These findings suggest that BRVO is a local indicator of systemic vascular dysfunction. The "hyper-sensitivity" of BRVO patients' arteries to aging and blood pressure highlights a potentially unique underlying pathophysiology. The study identifies 0.04% per mmHg as a possible "red line" for vascular risk, suggesting that baPWV-derived distensibility could serve as a valuable, non-invasive screening tool in ophthalmic clinics.
However, the study is limited by its relatively small sample size (n=70) and the potential masking effect of anti-hypertensive medications already taken by many BRVO patients. Future research should expand to include Central Retinal Vein Occlusion (CRVO) to determine if these systemic vascular patterns hold across different types of retinal vein occlusions.
Conclusion
Peripheral arterial distensibility is significantly reduced in patients with BRVO compared to normal subjects. This systemic stiffening, exacerbated by age and blood pressure, underscores the need for comprehensive cardiovascular monitoring in patients presenting with retinal vascular occlusions.
Summary updated